Several recent observations by others and us indicated that programmed death-1 (PD-1)/PD ligand 1 (PD-L1) interactions could play a role in the regulation of synovial T cell hyporesponsiveness to (TSLP-primed) mDCs from RA patients. This evidence concerns the gene TSLP and rheumatoid arthritis.